The advisers of US Food and Drug Administration (FDA) gave their nod to CAR-T Immunotherapy for treating different forms of cancers.This therapy genetically engineers the patient’s own immune cells to target the cancerous ones and destroy them.

Reference Link:

Views : 1211

Leave a Reply

Your email address will not be published. Required fields are marked *

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.